|[December 05, 2013]
Getinge Group: Shareholders Representing 70% of Outstanding Shares in Pulsion Have Agreed to Accept Getinge's Offer in Intended Acquisition of Pulsion Medical Systems
GETINGE, Sweden --(Business Wire)--
As announced yesterday, Getinge (STO:GETIB) has decided to issue a
public tender offer to acquire all shares in Pulsion Medical Systems SE
("Pulsion"), listed on the German Stock Exchange (Deutsche Börse).
Getinge plans to offer the shareholders in Pulsion to tender their
shares for an offer price of 16.90 € per share in cash. The offer will
be made by a fully-owned German Getinge subsidiary in accordance with
the German Securities and Takeover Act. The offer will be subject to the
terms and conditions to be set forth in the offer document.
A shareholder pool led by Forum European Smallcaps GmbH and a number of
other shareholders, who together represent approximately 70% of all
issued shares and voting rights in Pulsion, have irrevocably undertaken
to accept the offer from Getinge.
Dr. Wittek, Chairman of Pulsion's Board of Directors, has stated that
Pulsion cosiders the offer to be a great opportunity to combine its
leading position in hemodynamic monitoring in Europe with the global
sales and marketing power of Getinge. After review of the offer
document, the Board of Directors of Pulsion will provide a final
recommendation to the shareholders.
To read the press announcement from yesterday please visit www.getingegroup.com
where, as soon as completed, the offer document also will be published.
GETINGE GROUP is a leading global provider of products and systems that
contribute to quality enhancement and cost efficiency within healthcare
and life sciences. We operate under the three brands of ArjoHuntleigh,
GETINGE and MAQUET. ArjoHuntleigh focuses on patient mobility and wound
management solutions. GETINGE provides solutions for infection control
within healthcare and contamination prevention within life sciences.
MAQUET specializes in solutions, therapies and products for surgical
interventions, interventional cardiology and intensive care. The
information is such that Getinge AB must disclose in accordance with the
Swedish Securities Market Act and/or the Financial Instruments Trading
This information was brought to you by Cision http://news.cision.com
[ Back To Technology News's Homepage ]